Home › Therapeutic areas › Neurology › Smith-Magenis Syndrome
Smith-Magenis Syndrome (1 companies)
Companies with an active program in Smith-Magenis Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 1 | Approved | 26 |
No companies match.